ENTITY CLASS
Melanocortin agonists
Approved bremelanotide evidence and unapproved Melanotan II claims compared by product and indication.
CONNECTED RECORDS
Melanocortin agonists: evidence by entity.
Melanocortin receptor agonistHuman evidence 5/5
PT-141 / Bremelanotide
PT-141 is commonly marketed more broadly than the evidence allows. The decision-grade record concerns FDA-reviewed bremelanotide, its subcutaneous formulation, and one narrow population and indication.
Open evidence recordMelanocortin receptor agonistHuman evidence 1/5
Melanotan II
Melanotan II has no approved tanning or sexual-health use, and the available human record provides more reason for safety concern than confidence in benefit.
Open evidence record